Contact Me | QA VALIDATION ENGINEER CONSULTANT (UK)

+44 79 19 49 39 39 wilsonblaney@gmail.com

Home
LinkedIn Profile
- CV
- Clients
Contact Me
cGMP Reference Guides
Validation Protocols
Blog
- Privacy Policy
- Copyright

Select Page

MHRA Drug Safety Alerts

Daratumumab (Darzalex▼): risk of reactivation of hepatitis B virus August 19, 2019
Naltrexone/bupropion (Mysimba▼): risk of adverse reactions that could affect ability to drive August 19, 2019

MHRA Recall Notices

Class 2 Medicines Recall: Aripiprazole 1mg/ml oral solution (EL (19)A/20) July 30, 2019
FMD Alert: Class 2 (EL (19)A/19) July 25, 2019

FDA Recall Notices

The Lennox Intl Inc is Voluntary Recalling Natural Pig Ears on July 26, 2019 August 25, 2019
Pregel America, Inc. Issues Allergy Alert on Undeclared Milk in Lemon 50 August 25, 2019

Categories

EudraLex
FDA Latest News
MHRA News
Novartis
Pharmaceutical Validation Blog
Process Validation Engineer

Recent Posts

Doctors pounce on ‘alarmist,’ ‘horrifying’ Novartis heart-failure ad February 23, 2016
Latest Novartis News February 18, 2016

Home
LinkedIn Profile
Contact Me
cGMP Reference Guides
Validation Protocols
Blog

Designed by Elegant Themes | Powered by WordPress